A Phase I, Randomised, Double-Blinded, Placebo Controlled, Safety and Pharmacokinetic Study of (Z)-Endoxifen Tablets in Healthy Female Volunteers
Latest Information Update: 20 Mar 2020
At a glance
- Drugs Endoxifen (Primary)
- Indications Breast cancer
- Focus Pharmacokinetics
- Sponsors Atossa Genetics; Atossa Therapeutics
Most Recent Events
- 19 Mar 2020 Status changed from recruiting to completed.
- 27 Nov 2019 Status changed from not yet recruiting to recruiting, as reported by Australian New Zealand Clinical Trials Registry record.
- 26 Nov 2019 New trial record